Tag: #LiverInjury

Introduction Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, has seen major therapeutic advances with the introduction of biologic medications. While these treatments have transformed patient outcomes concerns about liver safety remain critical. This article explores a comprehensive systematic review and meta-analysis examining the risk of drug-induced liver injury (DILI) associated with biologics…